Loading company details...
Beta
Latest Form 4 (Oct 13, 2026): Gilbert Lynn Marks (Director): Grant/Award of 2,283 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Gilbert Lynn Marks | Grant/Award | 2,283 | n/a |
| Oct 13, 2026 | Patricia A. Martin | Grant/Award | 389 | n/a |
| Oct 13, 2026 | Kabeer Aziz | Grant/Award | 2,465 | n/a |
| Sep 16, 2026 | Cameron C. Trenor III, Chief Medical Officer | Grant/Award | 116,667 | n/a |
| Sep 11, 2026 | Robin Shane Readnour | Sale | 523 | $3.2K |
| Sep 8, 2026 | Robin Shane Readnour | Sale | 2,877 | $17.5K |
| Sep 4, 2026 | Sarah Joanne Williams, Principal Accounting Officer | Sale | 272 | $1.5K |
| Sep 2, 2026 | Margaret M. FitzPatrick | Purchase | 2,098 | $11.6K |
| Aug 19, 2026 | Robin Shane Readnour | Sale | 16,696 | $100.3K |
| Aug 14, 2026 | Joseph S. Zakrzewski | Gift | 405,880 | n/a |